JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Biochemical Reagent
Signaling pathways

Signaling pathways

BA5261 CCX354

Summary: CCX354 is a potent antagonist.
BA5262 CKLF1-C27

Summary: CKLF1-C27 is a C-terminal peptide of CKLF1 that binds to the receptor and activates the pathway.
BA5263 Ubrogepant

≥53.7 mg/mL
BA5264 Atogepant

Summary: Atogepant (MK-8031) is an orally effective and selective antagonist.
BA5265 Cagrilintide

Summary: Cagrilintide is a novel long-acting acylated glucagon analog under investigation as a non-selective agonist of the amylin receptor (AMYR) and calcitonin G protein-coupled receptor (CTR).
BA5266 Vazegepant

Summary: Vazegepant (Zavegepant) is an orally effective calcitonin gene-related peptide receptor antagonist with potential for acute studies in migraine.

≥52.4 mg/mL
BA5267 ChemR23-IN-1

Summary: ChemR23-IN-1 is an inhibitor at 38 nM and 100 nM for human and mouse, respectively.
BA5268 Pentagastrin

Summary: Pentagastrin (ICI-50123) is a potent and selective cholecystokinin B receptor antagonist.

≥10.74 mg/mL
BA5269 Devazepide

Summary: Devazepide (L-364,718) is a potent, competitive, selective, orally available, nonpeptide cholecystokinin receptor antagonist with values of 81pM, 45pM and 245nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively.
BA5271 Sograzepide

Summary: Sograzepide (Netazepide; YF476; YM-220) is a very potent, highly selective and orally active antagonist.